4Kondas J,Kiss L,Hatar A,et al.The effect of intravesical mitomycin C on the recurrence of superficial(Ta2T1)bladder cancer[J].A 77 Hungarian Multi-center Study.Int Urol Nephrol,1999,31(4):451-56.
10Okamura K,Murase T,Obata K.A randomized trial of early intravesical instillation of EPI rubicin in superficial bladder cancer[J].Cancer Chemother Pharmacol,1994,Suppl:S31-35.
3Vander Meijden AP, Kurth KH, Oosterlinck W. Intravesical therapy with adriamycin and 4-EPI rubicin for superficial bladder cancer: the experience of the EOR TC GU Group[J].Cancer Chemother Pharmacol, 1992; 30 (Suppl): S95-98
4Maekawa S, Suzuki H, Ohkubo K. Continuous intravesical instillation of EPI rubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study[J]. Hinyokika Kiyo, 2000; 46(5): 301-306
5Hirao Y, Ozono S, Momose H. Prospective randomized study of prophylaxis of superficial bladder cancer with EPI rubicin: the role of a central pathology laboratory[J]. Cancer Chemother Pharmacol, 1994; 35 Suppl: S36-40
6Melekos MD, Dauaher H, Fokaefs E. Intravesical instillations of4-EPI-doxorubicin (EPI rubicin) in the prophylactic treatment of superficial bladder cancer: results of a controlled prospective study[J]. J Urol, 1992; 147(2): 371-375
7Melekos MD, Chionis HS, Paranychianakis GS. Intravesical 4-EPI-doxorubicin (EPI rubicin) versus bacillus Calmette-Guerin. A controlled prospective study on the prophylaxis of superficial bladder cancer[J]. Cancer, 1993; 72(5): 1 749-1755
8Oosterlinck W, Kurth KH, Schroder F. A prospective European Organization for R.esearch and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of EPI rubicin or water in
9Raitanen MP, Lukkarinen O. A controlled study of intravesical EPI rubicin with or without alpha 2b-interferon as prophylaxis for recurrent superficial transitonal cell carcinoma of the bladder. Finnish Multicentre Study Group [J ]. Br J Urol,1995; 76(6):
10The Hokkaido University Bladder Cancer Collaborative Group. Prophylactic chemotherapy with anthracyclines ( adriamycin, EPI rubicin, and pirarubicin) for primary superficial bladder cancer[J]. Cancer Chemother Pharmacol, 1994; 35(Suppl): S41-45
